SVA [SINOVAC BIOTECH] 6-K: Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee

[Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement Press Release: Sinovac Biotech Co., Ltd. – Tue, Jan 24, 2012 4:05 PM EST BEIJING, Jan. 24, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of vaccines in China, today announced that it received a letter dated January 18, 2012 from The Nasdaq Stock Market. Based] [Sinovac Commences the Phase III Clinical Trial for its EV71 Vaccine Against Hand, Foot and Mouth Disease Press Release: Sinovac Biotech Ltd. – Tue, Jan 10, 2012 8:00 AM EST BEIJING , Jan. 10, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of biopharmaceutical products in China , announced today that the phase III clinical] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F ¨ SINOVAC BIOTECH LTD. 6-K 1 v301323_6k.htm FORM 6-K]

By | 2016-03-24T01:26:07+00:00 February 6th, 2012|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

HTHT [China Lodging,] CORRESP: February6, 2012 VIA EDGAR STYLE=”font-family:Times New Roman” SIZE=”2″>

[February6, 2012 VIA EDGAR STYLE="font-family:Times New Roman" SIZE="2"> Division ofrporation Finance 100 F Street, N.E. Mail Stop 3010 Attention: Kevin Woody, Branch Chief Howard Efron, Senior Staff Accountant Re: China Lodging, Limited Form 20-F for the year ended December31, 2010 filed on April7, 2011 (File No.1-34656) Dear Mr.Woody and Mr.Efron,]

By | 2016-02-07T11:47:50+00:00 February 6th, 2012|Categories: Chinese Stocks, HTHT, Webplus ver|Tags: , , , , , |0 Comments

SGOC [SGOCO] SC 13D: (Original Filing)

[Sze Kit Ting 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o b) o 3 SEC USE ONLY 4 SOURCE OF FUNDS 5 o 6 CITIZENSHIP OR PLACE OF ORGANIZATION NUMBER OF 7 2,860,000 Shares SOLE VOTING POWER 8 0 Shares SHARED VOTING POWER 9 2,860,000 Shares SOLE DISPOSITIVE POWER 10 0 Shares SHARED DISPOSITIVE POWER]

VNET [21Vianet] SC 13G: (Original Filing)

[JOINT FILING AGREEMENT Dated: February 2, 2012 Matrix Partners China I, L.P. David Su Director Matrix Partners China I-A, L.P. David Su Director Matrix China Management I, L.P. David Su Director Matrix China I GP GP, Ltd. David Su] [SCHEDULE 13G (Rule 13d–102) (Amendment No. _________) * 21Vianet Group, Inc. (Name of Issuer) Class A Ordinary Shares, par value US$0.00001 per share (Title of Class of Securities) 90138A 10 3 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) o Rule 13d-1(b) o Rule 13d-1(c) x Rule 13d-1(d) *The remainder of this cover page]

Skip to toolbar